AIM
TWST icon

ARK Investment Management’s Twist Bioscience TWST Stock Holding History

ARK Investment Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$301M Sell
6,342,733
-1,216,762
-16% -$54.6M 2.34% 13
2025
Q4 		$240M Buy
7,559,495
+832,687
+12% +$26M 1.59% 18
2025
Q3 		$189M Buy
6,726,808
+326,367
+5% +$9.89M 1.13% 25
2025
Q2 		$235M Buy
6,400,441
+158,846
+3% +$5.49M 1.73% 15
2025
Q1 		$245M Buy
6,241,595
+645,730
+12% +$29.1M 2.45% 10
2024
Q4 		$260M Buy
5,595,865
+237,772
+4% +$10.7M 2.17% 13
2024
Q3 		$242M Sell
5,358,093
-771,282
-13% -$36.7M 2.21% 13
2024
Q2 		$302M Sell
6,129,375
-814,600
-12% -$33.2M 2.68% 11
2024
Q1 		$238M Sell
6,943,975
-269,282
-4% -$9.72M 1.65% 18
2023
Q4 		$266M Buy
7,213,257
+427,274
+6% +$9.88M 1.57% 19
2023
Q3 		$137M Sell
6,785,983
-173,257
-2% -$3.81M 1.05% 24
2023
Q2 		$142M Sell
6,959,240
-219,872
-3% -$3.29M 0.94% 24
2023
Q1 		$108M Buy
7,179,112
+478,257
+7% +$10.6M 0.74% 24
2022
Q4 		$160M Buy
6,700,855
+23,947
+0.4% +$694K 1.38% 22
2022
Q3 		$235M Buy
6,676,908
+409,187
+7% +$17.4M 1.64% 21
2022
Q2 		$213M Buy
6,267,721
+1,003,466
+19% +$35.5M 1.26% 23
2022
Q1 		$260M Buy
5,264,255
+1,497,052
+40% +$83M 1.09% 24
2021
Q4 		$292M Sell
3,767,203
-179,206
-5% -$18.4M 0.88% 31
2021
Q3 		$422M Sell
3,946,409
-1,108,455
-22% -$127M 1.01% 26
2021
Q2 		$674M Sell
5,054,864
-990,656
-16% -$115M 1.25% 25
2021
Q1 		$749M Buy
6,045,520
+168,549
+3% +$25.6M 1.49% 16
2020
Q4 		$830M Buy
5,876,971
+2,716,493
+86% +$301M 2.21% 9
2020
Q3 		$240M Buy
3,160,478
+1,516,988
+92% +$94.4M 1.42% 21
2020
Q2 		$74.5M Buy
1,643,490
+999,397
+155% +$35.9M 0.8% 33
2020
Q1 		$19.7M Buy
644,093
+245,480
+62% +$6.6M 0.49% 43
2019
Q4 		$8.37M Buy
398,613
+152,986
+62% +$3.58M 0.21% 61
2019
Q3 		$5.87M Buy
245,627
+31,834
+15% +$925K 0.13% 68
2019
Q2 		$6.2M Buy
+213,793
New +$5.66M 0.16% 68

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ARK Investment Management's TWST Position: Q1 2026 in Review

ARK Investment Management reduced its Twist Bioscience (TWST) stake by 16% in Q1 2026, selling an estimated $54.6M and leaving 6,342,733 shares worth $301M. The position accounts for 2.34% of the portfolio, ranked #13.

ARK Investment Management first reported a position in TWST in Q2 2019 and has held it in 28 quarters since. The position peaked at $830M in Q4 2020. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • ARK Investment Management held 6,342,733 shares of Twist Bioscience worth $301M as of Q1 2026.
  • ARK Investment Management sold 1,216,762 Twist Bioscience shares in Q1 2026, an estimated $54.6M.
  • Twist Bioscience made up 2.34% of ARK Investment Management's portfolio in Q1 2026, its #13 holding.
  • ARK Investment Management first reported a position in Twist Bioscience in Q2 2019 and has held it in 28 quarters since.
  • ARK Investment Management's Twist Bioscience position peaked at $830M in Q4 2020.
  • 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on ARK Investment Management's 13F filing for Q1 2026, filed 12 May 2026.